SGM
IDYA icon

Seven Grand Managers’s IDEAYA Biosciences IDYA Stock Holding History

Seven Grand Managers’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
+50,000
New +$1.53M 0.08% 142
2022
Q4 		– Sell
-10,000
Closed -$149K – 18
2022
Q3 		$149K Buy
+10,000
New +$130K 0.49% 20

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Seven Grand Managers's IDYA Position: Q2 2026 in Review

Seven Grand Managers opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 50,000 shares worth $1.86M. The stake represents 0.08% of the portfolio and ranks #142 among its holdings. This is a return to the name: Seven Grand Managers previously reported a position in IDYA as recently as Q3 2022.

Seven Grand Managers first reported a position in IDYA in Q3 2022 and has held it in 2 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Seven Grand Managers held 50,000 shares of IDEAYA Biosciences worth $1.86M as of Q2 2026.
  • IDEAYA Biosciences was a new Seven Grand Managers position in Q2 2026.
  • IDEAYA Biosciences made up 0.08% of Seven Grand Managers's portfolio in Q2 2026, its #142 holding.
  • Seven Grand Managers first reported a position in IDEAYA Biosciences in Q3 2022 and has held it in 2 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Seven Grand Managers's 13F filing for Q2 2026, filed 14 Aug 2026.